LivaNova PLC LIVN · Stock Open LivaNova PLC in new tab
LivaNova PLC Analysis (LIVN)
Is LivaNova PLC a good investment? LivaNova PLC (LIVN) is currently trading at 69.87 USD. Market analysts have a consensus price target of 74.55 USD. This suggests a potential upside from current levels.
Earnings Schedule: LivaNova PLC is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 4.50.
Investor FAQ
Does LivaNova PLC pay a dividend?
No, it does not currently pay a dividend.
What asset class is LivaNova PLC?
LivaNova PLC is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of -3.98.
Company Profile
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Community Discussion